captopril has been researched along with Extravascular Hemolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, GX; Liu, ZQ | 1 |
| Homeister, JW; Kilgore, KS; Lucchesi, BR; Satoh, PS | 1 |
| Bartosz, G; Bartosz, M; Kedziora, J | 1 |
3 other study(ies) available for captopril and Extravascular Hemolysis
| Article | Year |
|---|---|
Captopril and 6-mercaptopurine: whose SH possesses higher antioxidant ability?
Topics: Antioxidants; Captopril; Erythrocytes; Free Radical Scavengers; Hemin; Hemolysis; Humans; Mercaptopurine; Molecular Structure; Sulfhydryl Compounds | 2009 |
Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.
Topics: Animals; Captopril; Cardiomyopathies; Complement System Proteins; Coronary Circulation; Enalaprilat; Erythrocytes; Hemolysis; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Pressure; Rabbits; Sulfhydryl Compounds; Tiopronin | 1994 |
Antioxidant and prooxidant properties of captopril and enalapril.
Topics: Adenosine Triphosphatases; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Captopril; Deoxyribose; DNA Damage; Enalapril; Erythrocyte Membrane; Hemolysis; Humans; Lipid Peroxidation; Oxidation-Reduction | 1997 |